DowDuPont on Wednesday, April 17 announced three new members to the future board of directors of DuPont, currently the Specialty Products Division of DowDuPont.
DuPont expects to have 12 members on its board by June 1, when the final spin-off of Corteva Agriscience is set to take place.
“We’re excited to welcome Frank Clyburn, Terrence Curtin, and Fred Lowery to the future DuPont board,” said Marc Doyle, CEO-elect of DuPont. “Their diverse perspectives and expertise will be invaluable as we leverage our proprietary technology and deep customer relationships to drive innovation in attractive high-growth markets.”
The new directors include Frank K. Clyburn, chief commercial officer at Merck & Co., Inc., Terrence R. Curtin, CEO of TE Connectivity, and Frederick M. Lowery, senior vice president and president, Life Sciences Solutions and Laboratory Products at Thermo Fisher Scientific Inc.
“DuPont’s board of directors is composed of highly qualified leaders, with the right mix of skills and experience to position the independent company to drive sustainable growth,” said Ed Breen, executive chairman-elect of DuPont and current Chair and CEO of DowDuPont. “The new directors bring deep global expertise in electronics and pharmaceuticals, as well as manufacturing, further strengthening the overall board, which will work closely with the management team to oversee the successful execution of DuPont’s strategy and enhance value for shareholders.”
